[Federal
Register Volume 84, Number 18 (Monday, January 28, 2019)]
[Notices]
SUMMARY:
On June 29, 2016, the United States Patent and Trademark
Office
(USPTO) implemented the Cancer Immunotherapy Pilot Program,
which
permits patent applications pertaining to cancer immunotherapy to
be
advanced out of turn for examination and reviewed earlier (accorded
special
status). To date, over 300 petitions requesting participation
in
the pilot program have been filed, and over 100 patents have been
granted
under the pilot program. In view of the continued interest in
the
pilot program, the USPTO has extended the pilot program until June
30,
2020. All pilot parameters remain the same as the original pilot.
DATES:
Duration: The Cancer Immunotherapy Pilot Program will continue
to
run until June 30, 2020. Therefore, petitions to make special under
the
Cancer Immunotherapy Pilot Program must be filed on or before June
30,
2020. In addition, any petition to make special under the Cancer
Immunotherapy
Pilot Program filed between December 31, 2018, and the
publication
date of this notice will be considered timely. The USPTO
may
further extend the pilot program (with or without modifications) or
terminate
it depending on feedback received, continued interest and the
effectiveness
of the pilot program.
FOR
FURTHER INFORMATION CONTACT: Pinchus M. Laufer, Patent
Attorney (telephone (571) 272-7726; electronic mail at pinchus.laufer@uspto.gov)
or Susy Tsang-Foster, Senior Legal Advisor (telephone (571) 272-7711;
Attorney (telephone (571) 272-7726; electronic mail at pinchus.laufer@uspto.gov)
or Susy Tsang-Foster, Senior Legal Advisor (telephone (571) 272-7711;
electronic
mail at susy.tsang-foster@uspto.gov),
of the Office of Patent
Legal
Administration, Office of the Deputy Commissioner for Patent Examination Policy.
Administration, Office of the Deputy Commissioner for Patent Examination Policy.
For questions relating to a specific petition, please contact Gary
B.
Nickol, Supervisory Patent Examiner (telephone (571) 272-0835;
electronic
mail at gary.nickol@uspto.gov)
or Brandon J. Fetterolf,
Supervisory
Patent Examiner (telephone (571) 272-2919; electronic mail
at
brandon.fetterolf@uspto.gov),
of Technology Center 1600.
SUPPLEMENTARY INFORMATION: Please click here.
Dated:
January 18, 2019.
Andrei
Iancu,
Under
Secretary of Commerce for Intellectual Property and Director of
the
United States Patent and Trademark Office.
[FR
Doc. 2019-00202 Filed 1-25-19; 8:45 am]
BILLING CODE 3510-16-P